Last $4.35 USD
Change Today +0.03 / 0.69%
Volume 5.4K
BVX On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

bovie medical corp (BVX) Snapshot

Open
$4.28
Previous Close
$4.32
Day High
$4.37
Day Low
$4.14
52 Week High
06/2/14 - $5.00
52 Week Low
12/5/13 - $1.94
Market Cap
77.9M
Average Volume 10 Days
24.9K
EPS TTM
$-0.36
Shares Outstanding
17.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BOVIE MEDICAL CORP (BVX)

Related News

No related news articles were found.

bovie medical corp (BVX) Related Businessweek News

No Related Businessweek News Found

bovie medical corp (BVX) Details

Bovie Medical Corporation, an energy-based medical device company, develops, manufactures, and markets a range of electrosurgical products and technologies, and related medical products worldwide. The company’s electrosurgery products include desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It also offers battery operated cauteries; and battery operated medical lights for use in ophthalmology, as well as for general surgery, hip replacement surgery, and the placement of endotracheal tubes in emergency and surgical procedures. In addition, the company manufactures physicians’ office use penlights; and a nerve locator stimulator used for identifying motor nerves in hand and facial reconstructive surgery. Further, Bovie Medical Corporation is developing Derm 101 and Derm 102 products, which are 10 watt high frequency desiccators for use in family practice, aesthetics, and dermatology settings; and Seal-N-Cut, a disposable endoscopic surgical handle. The company markets its products through medical distributors to hospitals, doctor’s offices, and other healthcare facilities. Bovie Medical Corporation was founded in 1982 and is based in Clearwater, Florida.

136 Employees
Last Reported Date: 05/8/14
Founded in 1982

bovie medical corp (BVX) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $56.7K
President, Chief Sales & Marketing Officer an...
Total Annual Compensation: $305.2K
Executive Chairman
Total Annual Compensation: $215.5K
Senior Vice President
Total Annual Compensation: $204.8K
Vice President of Sales & Marketing - Surgica...
Total Annual Compensation: $160.1K
Compensation as of Fiscal Year 2013.

bovie medical corp (BVX) Key Developments

Bovie Medical Corporation Announces Unaudited Consolidated Financial Results for the Second Quarter and Half Year Ended June 30, 2014

Bovie Medical Corporation announced unaudited consolidated financial results for the second quarter and half year ended June 30, 2014. For the quarter, sales were $6,945,000 against $6,042,000 a year ago. Loss from operations was $1,746,000 against $1,650,000 a year ago. Pre-tax loss was $332,000 against $1,673,000 a year ago. Net income attributable to common shareholders was $29,000 or $0.07 per diluted share against net loss attributable to common shareholders of $1,119,000 or $0.06 per basic and diluted share a year ago. Adjusted non-GAAP net loss was $460,000 or $0.03 per basic and diluted share against $460,000 or $0.03 per basic and diluted share a year ago. The adjusted operating loss, which excludes the previously-mentioned inventory write-down and $383,000 related to CFO transition and other charges, was $520,000 compared to an adjusted operating loss of $609,000 in the prior year which excludes the $1.0 million impact of a legal award. For the half year, sales were $13,427,000 against $11,738,000 a year ago. Loss from operations was $1,687,000 against $2,315,000 a year ago. Pre-tax loss was $9,901,000 against $2,428,000 a year ago. Net loss attributable to common shareholders was $9,782,000 or $0.55 per basic and diluted share against $1,529,000 or $0.09 per basic and diluted share a year ago. Adjusted non-GAAP net loss was $536,000 or $0.03 per basic and diluted share against $836,000 or $0.05 per basic and diluted share a year ago.

Bovie Medical Corporation to Report Q2, 2014 Results on Aug 05, 2014

Bovie Medical Corporation announced that they will report Q2, 2014 results at 5:00 PM, Eastern Standard Time on Aug 05, 2014

Bovie Medical Corporation, Q2 2014 Earnings Call, Aug 05, 2014

Bovie Medical Corporation, Q2 2014 Earnings Call, Aug 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BVX:US $4.35 USD +0.03

BVX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CONMED Corp $37.62 USD +0.02
Synergetics USA Inc $3.09 USD +0.02
View Industry Companies
 

Industry Analysis

BVX

Industry Average

Valuation BVX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.0x
Price/Book 8.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOVIE MEDICAL CORP, please visit www.boviemedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.